Aqueous Gel Composition for Administering Active Agents
Summary
The USPTO has published a new patent application, US20260083669A1, filed by Acousia Therapeutics GmbH. The application describes an aqueous gel composition useful for administering pharmaceutically active agents, particularly for transtympanic administration.
What changed
This document is a newly published patent application from the USPTO, specifically application US20260083669A1, filed by Acousia Therapeutics GmbH. The application details an aqueous gel composition designed for the administration of active pharmaceutical agents, with a particular focus on transtympanic delivery. Key components include specific percentages of surfactants, an alcohol, and water.
As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it is relevant for pharmaceutical companies and researchers in the drug delivery space, particularly those involved in otic formulations. Companies should be aware of this and similar patent filings as they relate to their own intellectual property strategies and product development pipelines.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
AQUEOUS GEL COMPOSITION
Application US20260083669A1 Kind: A1 Mar 26, 2026
Assignee
Acousia Therapeutics GmbH
Inventors
Sven Heymans, Peter Jan Robert Kool, Julia Eva Diederichs, Jonas Dyhrfjeld-Johnsen
Abstract
The present invention discloses an aqueous gel composition which is useful for administration of pharmaceutically active agents, in particular for transtympanic administration of pharmaceutically active agents. The aqueous gel composition comprises
at least one first surfactant in an amount from 10% to 30% by weight, based on the total weight of the composition,at least one second surfactant in an amount from 5% to 20% by weight, based on the total weight of the composition,at least one alcohol in an amount from 5% to 20% by weight, based on the total weight of the composition,and water in an amount of at least 30% by weight, based on the total weight of the composition.
CPC Classifications
A61K 9/06 A61K 31/381 A61K 47/10 A61K 47/24
Filing Date
2023-05-17
Application No.
18695511
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.